Like Siu, Dick can also be intrigued by the most recent analysis into understanding how some cancer cells are able to resist procedure and at some point even regrow the tumor.    Trials in glioblastoma, pancreatic most cancers, and ovarian most cancers are underway, with engineered cells getting further augmented with “logic gates” and �